Peregrine Capital Management LLC Acquires 45,490 Shares of Addus HomeCare Corporation $ADUS

Peregrine Capital Management LLC lifted its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 25,272.2% in the third quarter, HoldingsChannel.com reports. The fund owned 45,670 shares of the company’s stock after acquiring an additional 45,490 shares during the period. Peregrine Capital Management LLC’s holdings in Addus HomeCare were worth $5,389,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Royal Bank of Canada increased its position in shares of Addus HomeCare by 24.3% during the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after purchasing an additional 1,347 shares during the last quarter. Integrated Wealth Concepts LLC grew its position in Addus HomeCare by 8.2% during the first quarter. Integrated Wealth Concepts LLC now owns 7,844 shares of the company’s stock valued at $776,000 after buying an additional 596 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Addus HomeCare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after buying an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Addus HomeCare by 6.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after acquiring an additional 2,952 shares during the period. Finally, Jane Street Group LLC boosted its stake in Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock valued at $1,092,000 after acquiring an additional 8,780 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $109.72 on Friday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.66 and a current ratio of 1.66. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The stock has a market cap of $2.03 billion, a PE ratio of 23.49, a price-to-earnings-growth ratio of 1.35 and a beta of 0.92. The stock has a fifty day moving average of $113.11 and a 200-day moving average of $113.42.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 3rd. The company reported $1.56 EPS for the quarter, topping the consensus estimate of $1.53 by $0.03. The business had revenue of $362.30 million during the quarter, compared to the consensus estimate of $354.48 million. Addus HomeCare had a return on equity of 9.53% and a net margin of 6.36%.The firm’s revenue was up 25.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.30 EPS. Equities research analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Insider Activity at Addus HomeCare

In other news, EVP Darby Anderson sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total value of $2,180,000.00. Following the completion of the transaction, the executive vice president directly owned 44,144 shares in the company, valued at approximately $4,811,696. This trade represents a 31.18% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold 20,316 shares of company stock valued at $2,215,998 in the last three months. 4.50% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on ADUS shares. Royal Bank Of Canada raised their price target on shares of Addus HomeCare from $134.00 to $139.00 and gave the stock an “outperform” rating in a research note on Friday, November 7th. Truist Financial set a $135.00 price objective on Addus HomeCare and gave the company a “buy” rating in a report on Wednesday. Cowen restated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, October 8th. Finally, Barclays increased their price target on Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and an average target price of $136.90.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.